Improving visual memory, attention, and school function with atomoxetine in boys with attention-deficit/hyperactivity disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 22, Issue 5, 2012, Pages 353-363

  Shang, Chi Yung ^a   Gau, Susan Shur Fen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE;

ACADEMIC ACHIEVEMENT; ADOLESCENT; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; CAMBRIDGE NEUROPSYCHOLOGICAL TEST AUTOMATED BATTERY; CHILD; CLINICAL ARTICLE; CONNER CONTINUOUS PERFORMANCE TEST; DRUG DOSE INCREASE; DRUG EFFICACY; HUMAN; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OPEN STUDY; PATTERN RECOGNITION; RECOGNITION; RESPONSE TIME; SCHOOL CHILD; SOCIAL ADJUSTMENT INVENTORY FOR CHILDREN AND ADOLESCENTS; SPATIAL RECOGNITION MEMORY; TAIWAN; TASK PERFORMANCE; TREATMENT DURATION; VISUAL MEMORY; WECHSLER INTELLIGENCE SCALE;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR; CHILD; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; MALE; MEMORY; NEUROPSYCHOLOGICAL TESTS; PATTERN RECOGNITION, VISUAL; PROPYLAMINES; PSYCHOMETRICS; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SCHOOLS; SOCIAL ADJUSTMENT; SPACE PERCEPTION; TAIWAN; TREATMENT OUTCOME; VISUAL PERCEPTION; WECHSLER SCALES;

EID: 84867751165     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2011.0149     Document Type: Article

References (82)

1. Bakken RJ, Paczkowski M, Kramer HP, Axelson AA, Williams DW, Malcolm SK, Sumner CR, Kelsey DK: Effects of atomoxetine on attention-deficit/hyperactivity disorder in clinical pediatric treatment settings: A naturalistic study. Curr Med Res Opin 24:449-460, 2008. (Pubitemid 351294394)
2. Banich MT, Burgess GC, Depue BE, Ruzic L, Bidwell LC, Hitt-Laustsen S, Du YP, Willcutt EG.: The neural basis of sustained and transient attentional control in young adults with ADHD. Neuropsychologia 47:3095-3104, 2009.
3. Bari A, Eagle DM, Mar AC, Robinson ES, Robbins TW: Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats. Psychopharmacology 205:273-283, 2009.
4. Berman T, Douglas VI, Barr RG.: Effects of methylphenidate on complex cognitive processing in attention-deficit hyperactivity disorder. J Abnorm Psychol 108:90-105, 1999. (Pubitemid 29108313)
5. Biederman J, Faraone S, Milberger S, Guite J, Mick E, Chen L, Mennin D, Marrs A, Ouellette C, Moore P, Spencer T, Norman D, Wilens T, Kraus I, Perrin J: A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. Arch Gen Psychiatry 53:437-446, 1996. (Pubitemid 26149233)
6. Blondeau C, Dellu-Hagedorn F: Dimensional analysis of ADHD subtypes in rats. Biol Psychiatry 61:1340-1350, 2007. (Pubitemid 46855765)
7. Caballero J, Nahata MC: Atomoxetine hydrochloride for the treatment of attention-deficit/hyperactivity disorder. Clin Ther 25:3065-3083, 2003. (Pubitemid 38096145)
8. Carli M, Robbins TW, Evenden JL, Everitt BJ: Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res 9:361-380, 1983. (Pubitemid 13002330)
9. Castellanos FX, Tannock R, Castellanos FX, Tannock R: Neuroscience of attention-deficit/hyperactivity disorder: The search for endophenotypes. Nat Rev Neurosci 3:617-628, 2002. (Pubitemid 135706670)
10. Chamberlain SR, Del Campo N, Dowson J, Muller U, Clark L, Robbins TW, Sahakian BJ: Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biol Psychiatry 62:977-984, 2007. (Pubitemid 47562368)
11. Chamberlain SR, Muller U, Blackwell AD, Clark L, Robbins TW, Sahakian BJ: Neurochemical modulation of response inhibition and probabilistic learning in humans. Science 311:861-863, 2006. (Pubitemid 43228852)
12. Cheng JY, Chen RY, Ko JS, Ng EM: Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta- analysis and meta-regression analysis. Psychopharmacology 194:197-209, 2007. (Pubitemid 47457955)
13. Chiang HL, Gau SS, Ni HC, Chiu YN, Shang CY, Wu YY, Lin LY, Tai YM, Soong WT: Association between symptoms and subtypes of attention-deficit hyperactivity disorder and sleep problems/disorders. J Sleep Res 19:535-545, 2010.
14. Clayton EC, Williams CL: Glutamatergic influences on the nucleus paragigantocellularis: Contribution to performance in avoidance and spatial memory tasks. Behav Neurosci 114:707-712, 2000. (Pubitemid 30646561)
15. Collings RD: Differences between ADHD inattentive and combined types on the CPT. J Psychopathol Behav Assess 25:177-189, 2003. (Pubitemid 36687529)
16. Coull JT, Jones ME, Egan TD, Frith CD, Maze M: Attentional effects of noradrenaline vary with arousal level: Selective activation of thalamic pulvinar in humans. NeuroImage 22:315-322, 2004. (Pubitemid 38515837)
17. De Martino B, Strange BA, Dolan RJ: Noradrenergic neuromodulation of human attention for emotional and neutral stimuli. Psychopharmacology 197:127-136, 2008.
18. Egeland J, Johansen SN, Ueland T: Differentiating between ADHD sub-types on CCPT measures of sustained attention and vigilance. Scand J Psychol 50:347-354, 2009.
19. Egeland J, Kovalik-Gran I: Measuring several aspects of attention in one test: The factor structure of Conners's continuous performance test. J Atten Disord 13:339-346, 2010.
20. Egerhazi A, Berecz R, Bartok E, Degrell I: Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 31:746-751, 2007. (Pubitemid 46467055)
21. Eliason MJ, Richman LC: The Continuous Performance Test in learning disabled and nondisabled children. J Learn Disabil 20: 614-619, 1987.
22. Faraone SV, Biederman J, Spencer T, Michelson D, Adler L, Reimherr F, Seidman L: Atomoxetine and Stroop task performance in adult attention-deficit/ hyperactivity disorder. J Child Adolesc Psychopharmacol 15:664-670, 2005. (Pubitemid 41434370)
23. Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E, Doyle AE: Attention-deficit/hyperactivity disorder in adults: An overview. Biol Psychiatry 48:9-20, 2000. (Pubitemid 30407145)
24. Frazier TW, Demaree HA, Youngstrom EA: Meta-analysis of intellectual and neuropsychological test performance in attentiondeficit/ hyperactivity disorder. Neuropsychology 18:543-555, 2004. (Pubitemid 38944390)
25. Garnock-Jones KP, Keating GM: Atomoxetine: A review of its use in attention-deficit hyperactivity disorder in children and adolescents. Paediatr Drugs 11:203-226, 2009.
26. Gau SF, Soong WT: Psychiatric comorbidity of adolescents with sleep terrors or sleepwalking: A case-control study. Aust N Z J Psychiatry 33:734-739, 1999.
27. Gau SS: Parental and family factors for attention-deficit hyperactivity disorder in Taiwanese children. Aust N Z J Psychiatry 41:688-696, 2007. (Pubitemid 47189820)
28. Gau SS, Chiang HL: Sleep problems and disorders among adolescents with persistent and subthreshold attention-deficit/hyperactivity disorders. Sleep 32:671-679, 2009.
29. Gau SS, Chiu CD, Shang CY, Cheng AT, Soong WT: Executive function in adolescence among children with attention-deficit/hyperactivity disorder in Taiwan. J Dev Behav Pediatr 30:525-534, 2009.
30. Gau SS, Chong MY, Chen TH, Cheng AT: A 3-year panel study of mental disorders among adolescents in Taiwan. Am J Psychiatry 162:1344-1350, 2005. (Pubitemid 40905586)
31. Gau SS, Chong MY, Yang P, Yen CF, Liang KY, Cheng AT: Psychiatric and psychosocial predictors of substance use disorders among adolescents: Longitudinal study. Br J Psychiatry 190:42-48, 2007a. (Pubitemid 46121500)
32. Gau SS, Huang YS, Soong WT, Chou MC, Chou WJ, Shang CY, Tseng WL, Allen AJ, Lee P: A randomized, double-blind, placebocontrolled clinical trial on once-daily atomoxetine in taiwanese children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 17:447-460, 2007b. (Pubitemid 47417773)
33. Gau SS, Lin YJ, Shang CY, Liu SK, Chiu YN, Soong WT: Emotional/ behavioral problems and functional impairment in clinic- and community-based children with attention-deficit/hyperactivity disorder in Taiwan. J Abnorm Child Psychol 38:521-532, 2010.
34. Gau SS, Shang CY: Executive functions as endophenotypes in ADHD: Evidence from the Cambridge Neuropsychological Test Battery (CANTAB). J Child Psychol Psychiatry 51:838-849, 2010a.
35. Gau SS, Shang CY: Improvement of executive functions in boys with attention deficit hyperactivity disorder: An open-label follow-up study with once-daily atomoxetine. Int J Neuropsychopharmacol 13:243-256, 2010b.
36. Gau SS, Shen HY, Chou MC, Tang CS, Chiu YN, Gau CS: Determinants of adherence to methylphenidate and the impact of poor adherence on maternal and family measures. J Child Adolesc Psychopharmacol 16: 286-297, 2006a. (Pubitemid 43902425)
37. Gau SS, Shen HY, Soong WT, Gau CS: An open-label, randomized, active-controlled equivalent trial of osmotic release oral system methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan. J Child Adolesc Psychopharmacol 16:441-455, 2006b. (Pubitemid 44681464)
38. Gibbs ME: Memory systems in the chick: Regional and temporal control by noradrenaline. Brain Res Bull 76:170-182, 2008.
39. Gropper RJ, Tannock R: A pilot study of working memory and academic achievement in college students with ADHD. J Atten Disord 12:574-581, 2009.
40. John K, Gammon GD, Prusoff BA, Warner V: The Social Adjustment Inventory for Children and Adolescents (SAICA): Testing of a new semistructured interview. J Am Acad Child Adolesc Psychiatry 26:898-911, 1987. (Pubitemid 18010900)
41. Kawabata Y, Tseng WL, Gau SS: Symptoms of attention-deficit/ hyperactivity disorder and social and school adjustment: The moderating roles of age and parenting. J Abnorm Child Psychol 40:177-188, 2012
42. Kelly DL, Buchanan RW, Boggs DL, McMahon RP, Dickinson D, Nelson M, Gold JM, Ball MP, Feldman S, Liu F, Conley RR: A randomized double-blind trial of atomoxetine for cognitive impairments in 32 people with schizophrenia. J Clin Psychiatry 70:518-525, 2009.
43. Kempton S, Vance A, Maruff P, Luk E, Costin J, Pantelis C: Executive function and attention deficit hyperactivity disorder: Stimulant medication and better executive function performance in children. Psychol Med 29:527-538, 1999. (Pubitemid 29261342)
44. Lin YJ, Lai MC, Gau SS: Youths with ADHD with and without tic disorders: Comorbid psychopathology, executive function and social adjustment. Res Dev Disabil 33: 951-963, 2012.
45. Locke HS, Braver TS: Motivational influences on cognitive control: Behavior, brain activation, and individual differences. Cogn Affect Behav Neurosci 8:99-112, 2008.
46. Loe IM, Feldman HM: Academic and educational outcomes of children with ADHD. J Pediatr Psychol 32:643-654, 2007. (Pubitemid 47356042)
47. Lopez-Larson M, Michael ES, Terry JE, Breeze JL, Hodge SM, Tang L, Kennedy DN, Moore CM, Makris N, Caviness VS, Frazier JA: Subcortical differences among youths with attention-deficit/hyperactivity disorder compared to those with bipolar disorder with and without attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 19:31-39, 2009.
48. Lowe C, Rabbitt P: Test/re-test reliability of the CANTAB and ISPOCD neuropsychological batteries: Theoretical and practical issues. Cambridge Neuropsychological Test Automated Battery. International Study of Post-Operative Cognitive Dysfunction. Neuropsychologia 36:915-923, 1998.
49. Luciana M: Practitioner review: Computerized assessment of neuropsychological function in children: Clinical and research applications of the Cambridge Neuropsychological Testing Automated Battery (CANTAB). J Child Psychol Psychiatry 44:649-663, 2003. (Pubitemid 36943995)
50. Luciana M, Nelson CA: The functional emergence of prefrontallyguided working memory systems in four- to eight-year-old children. Neuropsychologia 36:273-293, 1998. (Pubitemid 28209957)
51. Moor T, Mundorff L, Bohringer A, Philippsen C, Langewitz W, Reino ST, Schachinger H: Evidence that baroreflex feedback influences long-term incidental visual memory in men. Neurobiol Learn Mem 84:168-174, 2005. (Pubitemid 41457372)
52. Navarra R, Graf R, Huang Y, Logue S, Comery T, Hughes Z, Day M: Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test. Prog Neuropsychopharmacol Biol Psychiatry 32:34-41, 2008.
53. Newman LA, Darling J, McGaughy J: Atomoxetine reverses attentional deficits produced by noradrenergic deafferentation of medial prefrontal cortex. Psychopharmacology 200:39-50, 2008.
54. Nichols SL, Waschbusch DA: A review of the validity of laboratory cognitive tasks used to assess symptoms of ADHD. Child Psychiatry Hum Dev 34:297-315, 2004. (Pubitemid 38992977)
55. Nieuwenhuis S, Aston-Jones G, Cohen JD: Decision making, the P3, and the locus coeruleus-norepinephrine system. Psychol Bull 131:510-532, 2005. (Pubitemid 41168494)
56. Owen AM, Sahakian BJ, Semple J, Polkey CE, Robbins TW: Visuospatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampectomy in man. Neuropsychologia 33:1-24, 1995.
57. Pattij T, Vanderschuren LJ: The neuropharmacology of impulsive behaviour. Trends Pharmacol Sci 29:192-199, 2008.
58. Posey DJ, Wiegand RE, Wilkerson J, Maynard M, Stigler KA, McDougle CJ: Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders. J Child Adolesc Psychopharmacol 16:599-610, 2006. (Pubitemid 44739916)
59. Rapport MD, Scanlan SW, Denney CB: Attention-deficit/ hyperactivity disorder and scholastic achievement: A model of dual developmental pathways. J Child Psychol Psychiatry 40: 1169-1183, 1999.
60. Rhodes SM, Coghill DR, Matthews K: Acute neuropsychological effects of methylphenidate in stimulant drug-nai've boys with ADHD II-broader executive and non-executive domains. J Child Psychol Psychiatry 47:1184-1194, 2006. (Pubitemid 44660621)
61. Rhodes SM, Coghill DR, Matthews K: Methylphenidate restores visual memory, but not working memory function in attention deficithyperkinetic disorder. Psychopharmacology 175:319-330, 2004. (Pubitemid 39361920)
62. Rhodes SM, Coghill DR, Matthews K: Neuropsychological functioning in stimulant-nai've boys with hyperkinetic disorder. Psychol Med 35:1109-1120, 2005. (Pubitemid 41103003)
63. Riccio CA, Waldrop JJ, Reynolds CR, Lowe P: Effects of stimulants on the continuous performance test (CPT): Implications for CPT use and interpretation. J Neuropsychiatry Clin Neurosci 13:326-335, 2001. (Pubitemid 32743710)
64. Robison RJ, Reimherr FW, Marchant BK, Faraone SV, Adler LA, West SA: Gender differences in 2 clinical trials of adults with attention-deficit/ hyperactivity disorder: A retrospective data analysis. J Clin Psychiatry 69:213-221, 2008. (Pubitemid 351469264)
65. Rossetti ZL, Carboni S: Noradrenaline and dopamine elevations in the rat prefrontal cortex in spatial working memory. J Neurosci 25:2322-2329, 2005. (Pubitemid 40322273)
66. Sahakian BJ, Morris RG, Evenden JL, Heald A, Levy R, Philpot M, Robbins TW: A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. Brain 111:695-718, 1988.
67. Sawyer MG, Rey JM, Arney FM, Whitham JN, Clark JJ, Baghurst PA: Use of health and school-based services in Australia by young people with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 43:1355-1363, 2004. (Pubitemid 39411035)
68. Seidman LJ: Neuropsychological functioning in people with ADHD across the lifespan. Clin Psychol Rev 26:466-485, 2006.
69. Semrud-Clikeman M, Pliszka S, Liotti M: Executive functioning in children with attention-deficit/hyperactivity disorder: Combined type with and without a stimulant medication history. Neuropsychology 22:329-340, 2008. (Pubitemid 351645173)
70. Seu E, Lang A, Rivera RJ, Jentsch JD: Inhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys. Psychopharmacology 202:505-519, 2009.
71. Shang CY, Gau SS: Visual memory as a potential cognitive endophenotype of attention deficit hyperactivity disorder. Psychol Med 41:2603-2614, 2011.
72. Sirvio J, MacDonald E: Central alpha1-adrenoceptors: Their role in the modulation of attention and memory formation. Pharmacol Ther 83:49-65, 1999. (Pubitemid 29430127)
73. Spencer T, Biederman J, Wilens T, Prince J, Hatch M, Jones J, Harding M, Faraone SV, Seidman L: Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. Am J Psychiatry 155:693-695, 1998. (Pubitemid 28225414)
74. Stavro GM, Ettenhofer ML, Nigg JT: Executive functions and adaptive functioning in young adult attention-deficit/hyperactivity disorder. J Int Neuropsychol Soc 13:324-334, 2007. (Pubitemid 46487362)
75. Tseng WL, Kawabata Y, Gau SS: Social adjustment among Taiwanese children with symptoms of ADHD, ODD, and ADHD comorbid with ODD. Child Psychiatry Hum Dev 42:134-151, 2011.
76. Tzavara ET, Bymaster FP, Overshiner CD, Davis RJ, Perry KW, Wolff M, McKinzie DL, Witkin JM, Nomikos GG.: Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine. Mol Psychiatry 11:187-195, 2006. (Pubitemid 43164620)
77. Valera EM, Faraone SV, Biederman J, Poldrack RA, Seidman LJ: Functional neuroanatomy of working memory in adults with attentiondeficit/ hyperactivity disorder. Biol Psychiatry 57:439-447, 2005. (Pubitemid 40311977)
78. Waxmonsky JG, Waschbusch DA, Pelham WE, Draganac-Cardona L, Rotella B, Ryan L: Effects of atomoxetine with and without behavior therapy on the school and home functioning of children with attention-deficit/hyperactivity disorder. J Clin Psychiatry 71:1535-1551, 2010.
79. Wehmeier PM, Schacht A, Wolff C, Otto WR, Dittmann RW, Banaschewski T: Neuropsychological outcomes across the day in children with attention-deficit/ hyperactivity disorder treated with atomoxetine: Results from a placebo-controlled study using a computer-based continuous performance test combined with an infra-red motion-tracking device. J Child Adolesc Psychopharmacol 21:433-444, 2011.
80. Wehmeier PM, Schacht A, Escobar R, Hervas A, Dickson R: Healthrelated quality of life in ADHD: A pooled analysis of gender differences in five atomoxetine trials. Atten Defic Hyperact Disord 4:25-35, 2012.
81. Wolosin SM, Richardson ME, Hennessey JG, Denckla MB, Mostofsky SH: Abnormal cerebral cortex structure in children with ADHD. Hum Brain Mapp 30:175-184, 2009.
82. Zhang J, He J, Chen YM, Wang JH, Ma YY: Morphine and propranolol co-administration impair consolidation of Y-maze spatial recognition memory. Brain Res 1230:150-157, 2008.